Αποτελέσματα Αναζήτησης
Learn about the benefits, risks, and uncertainties of prostate cancer screening and how to make an informed decision with your health care provider. The ACS recommends screening at different ages for men at different risk levels and based on PSA test results.
Clinical Practice Guidelines – Prostate Cancer. eUpdate 21 March 2023: Updated treatment recommendations for prostate cancer from the ESMO Clinical Practice Guideline considering treatment intensification and use of novel systemic agents. Published in 2020 – Ann Oncol (2020)
Κυριότερες Ειδήσεις
12 Απρ 2023 · PSA screening for prostate cancer should involve consideration of benefits and risks. Screening is associated with a small reduction in prostate cancer deaths; risks include overdiagnosis...
8 Μαΐ 2018 · The US Preventive Services Task Force (USPSTF) provides guidance on the benefits and harms of prostate-specific antigen (PSA)-based screening for prostate cancer. The recommendation is based on the individual's values, preferences, and risk factors, and is updated regularly.
1 Ιουλ 2023 · The Early Detection of Prostate Cancer Panel developed evidence- and consensus-based guideline statements to provide guidance in prostate cancer screening, initial and repeat biopsy, and biopsy technique.
7 Νοε 2020 · Updated prostate cancer guidelines are presented, addressing screening, diagnosis, and local treatment with curative intent. These guidelines rely on the available scientific evidence, and new insights will need to be considered and included on a regular basis.
25 Ιουν 2020 · This ESMO Clinical Practice Guideline provides key recommendations on the management of prostate cancer. •. Authorship includes a multidisciplinary group of experts from different institutions and countries in Europe. •. Key treatment recommendations are provided. •. Recommendations have been updated in the light of new evidence. Key words.
